An investing blog on CNBC.com warns potential investors about health care giant Johnson & Johnson.
The stock is already up more than 22 percent on the year, the blog entry says, and trading at a price/earnings ratio more than twice that of rival Abbott Laboratories. But the entry points out that investors are worried about the company’s prospects for organic growth, especially in light of its reputation still being in “recovery” ...
continue reading...
According to a story in the International Business Times, a batch of baby powder from a Johnson & Johnson plant in India was found to be contaminated with a carcinogen. That finding prompted the Food and Drug Administration to cancel Johnson & Johnson’s license to manufacture the powder at that plant.
In recent years, Johnson & Johnson has been obliged to recall nearly 300 million packages of over-the-counter medications, including Motrin, ...
continue reading...
A story in Forbes describes Johnson & Johnson’s new global branding campaign, which will cost the medical products giant an estimated $20 million to $30 million for the remainder of the year.
The campaign, the company’s first in more than a decade, features the tagline: “For all you love, Johnson & Johnson.”
According to Forbes, the company is trying to compensate for damage to its public reputation following several years marked by ...
continue reading...
A story in The Telegraph details the advice that British health regulators are providing for U.K. residents who received a “metal-on-metal” hip implant, in light of recent findings that up to half of the devices fail within six years.
Friction between the metal surfacing on both the implants’ ball and cup causes tiny filings of cobalt and chromium to break off. According to the story, that toxic debris “can seep into ...
continue reading...
A story in the Washington Post says that several Johnson & Johnson shareholders spoke of their dissatisfaction with the company during their annual meeting recently. Their complaints focused on a long string of product recalls, ethical lapses and excessive executive pay.
In 2010, the company’s McNeil Consumer Healthcare unit recalled more than 280 million packages of over-the-counter medications, which included Motrin, children’s Tylenol liquid and Benadryl.
Also in 2010, Johnson & Johnson’s ...
continue reading...
Before you get hip replacement surgery, an orthopedic surgeon generally performs several tests to help ensure a good outcome, according to the Mayo Clinic.
Fortunately, the success rates for hip replacement surgery are generally high, although they can vary based on the type of implant used.
For example, a number of studies have shown that nearly half of metal-on-metal hip implants – featuring both a ball and a socket coated in a ...
continue reading...
